Jindal Drugs Pvt Ltd (JINDALDRUG) — Share Price, Financials & Ratios

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Cash Flow from Financing

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Cash Flow from Investing

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Depreciation & Amortisation

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

EBIT

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

EBITDA

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

EBITDA Margin

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Equity Share Capital

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Finance Cost

▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓▓▓,▓▓▓

Log in to view Jindal Drugs Pvt Ltd insights

28 extracted metrics + investor summaries across FY09–FY20.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Weaknesses

3

The company has delivered a poor sales growth of -18.4% over past five years.
Company has a low return on equity of 10.4% over last 3 years.
Earnings include an other income of Rs.72.2 Cr.

Growth Rate

Revenue Growth

-8.00% →

Net Income Growth

-20.00% →

Cash Flow Change

-

ROE

8.00% ↗

ROCE

-

EBITDA Margin (Avg.)

-

Profit & Loss

	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Sales	364	536	414	1,101	955	940	866	311	319	400	340	314
Expenses	335	497	410	991	820	801	807	274	289	327	232	249
Operating Profit	29	39	5	110	135	138	59	37	30	73	108	65
OPM %	8%	7%	1.1%	10%	14%	15%	7%	12%	9%	18%	32%	21%
Other Income	9	30	33	25	38	19	38	31	36	131	52	72
Interest	0	1	2	36	11	20	6	4	2	3	2	5
Depreciation	9	13	9	11	15	18	25	16	17	16	14	13
PBT	28	54	27	87	146	120	65	48	47	185	143	120
Tax %	12%	16%	22%	19%	21%	21%	20%	15%	14%	22%	22%	25%
Net Profit	25	46	21	71	116	95	52	41	41	145	111	90
Div. Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Show % Change

Figures in ₹ Crores

Balance Sheet

	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	12	12	12	12	12	12	12	12	12	12	12	12
Reserves	407	453	474	545	661	757	809	948	848	993	1,104	1,194
Borrowings	39	113	97	108	152	155	143	158	8	120	44	196
Other Liabilities	24	35	26	43	95	71	64	94	147	155	156	153
Total Liabilities	482	613	609	707	920	995	1,028	1,212	1,015	1,280	1,316	1,555
Fixed Assets	110	100	94	107	162	171	253	238	162	148	135	124
CWIP	8	8	18	32	67	89	6	4	0	0	233	234
Investments	43	34	25	17	70	234	258	213	338	120	120	120
Other Assets	321	471	472	551	620	501	511	757	515	1,012	828	1,078
Total Assets	482	613	609	707	920	995	1,028	1,212	1,015	1,280	1,316	1,555

Show % Change

Figures in ₹ Crores

Cash Flow

	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Operating	—	—	—	—	—	120	65	129	201	139	138	-9
Investing	—	—	—	—	—	0	-128	52	50	-355	-71	-178
Financing	—	—	—	—	—	0	0	11	-148	110	-78	147
Net Cash Flow	—	—	—	—	—	120	-63	191	104	-107	-10	-39
Free Cash Flow	—	—	—	—	—	120	65	117	196	135	134	-9
CFO/OP	—	—	—	—	—	87	110	430	742	245	160	43

Show % Change

Figures in ₹ Crores

Ratios

	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Debtor Days	111	95	80	50	72	37	43	177	70	80	34	56
Inventory Days	36	28	28	26	41	67	96	199	74	122	158	192
Days Payable	9	11	6	5	24	16	7	20	7	13	17	11
Cash Conversion Cycle	137	111	102	71	88	88	131	356	137	189	175	238
Working Capital Days	216	158	190	92	110	57	99	210	123	105	20	-64
ROCE %	6%	10%	5%	20%	21%	16%	8%	4%	5%	17%	13%	10%

Show % Change

Frequently Asked Questions about Jindal Drugs Pvt Ltd

Where is Jindal Drugs Pvt Ltd (JINDALDRUG) listed?

Jindal Drugs Pvt Ltd is listed on the Indian stock exchanges. You can view its live share price, financials, and ratios on Tapetide.

How can I research Jindal Drugs Pvt Ltd on Tapetide?

On Tapetide, you can view Jindal Drugs Pvt Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.